newsfilter
← Latest News
Business Wire·

MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210

Human Immunology Biosciences (HIBio) is a biotechnology company focused on developing precision medicines for autoimmune and inflammatory diseases, backed by ARCH Venture Partners and Monograph Capital HIBio obtains exclusive worldwide rights, with t